Potent growth inhibitory activity of (±)-platencin towards multi-drug-resistant and extensively drug-resistant Mycobacterium tuberculosis

Gamal A I Moustafa, Shoji Nojima, Yoshi Yamano, Akio Aono, Masayoshi Arai, Satoshi Mitarai, Tetsuaki Tanaka, Takehiko Yoshimitsu

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The potent antimycobacterial activity of (±)-platencin is reported. Complete inhibition of Mycobacterium smegmatis growth was observed at MICs of 0.5 μg mL-1 and 0.3 μg mL-1 under aerobic and hypoxic conditions, respectively. Notably, the compound exhibited potent bacteriostatic activities towards Mycobacterium tuberculosis H37Rv (MIC = 2 μg mL-1), multi-drug-resistant M. tuberculosis (MIC = 1 μg mL-1), and extensively drug-resistant M. tuberculosis (MIC = 1 μg mL-1). An overexpression study of the transformants of M. smegmatis revealed that platencin selectively targeted Mt-KasB and modestly inhibited Mt-KasA and Mt-FabH.

Original languageEnglish
Pages (from-to)720-723
Number of pages4
JournalMedChemComm
Volume4
Issue number4
DOIs
Publication statusPublished - 2013
Externally publishedYes

Fingerprint

Extensively Drug-Resistant Tuberculosis
Mycobacterium smegmatis
Mycobacterium
Mycobacterium tuberculosis
Multidrug-Resistant Tuberculosis
Growth
Pharmaceutical Preparations
platencin

ASJC Scopus subject areas

  • Biochemistry
  • Pharmaceutical Science

Cite this

Potent growth inhibitory activity of (±)-platencin towards multi-drug-resistant and extensively drug-resistant Mycobacterium tuberculosis. / Moustafa, Gamal A I; Nojima, Shoji; Yamano, Yoshi; Aono, Akio; Arai, Masayoshi; Mitarai, Satoshi; Tanaka, Tetsuaki; Yoshimitsu, Takehiko.

In: MedChemComm, Vol. 4, No. 4, 2013, p. 720-723.

Research output: Contribution to journalArticle

Moustafa, Gamal A I ; Nojima, Shoji ; Yamano, Yoshi ; Aono, Akio ; Arai, Masayoshi ; Mitarai, Satoshi ; Tanaka, Tetsuaki ; Yoshimitsu, Takehiko. / Potent growth inhibitory activity of (±)-platencin towards multi-drug-resistant and extensively drug-resistant Mycobacterium tuberculosis. In: MedChemComm. 2013 ; Vol. 4, No. 4. pp. 720-723.
@article{30ba631b91ea4b219500253978a04bb3,
title = "Potent growth inhibitory activity of (±)-platencin towards multi-drug-resistant and extensively drug-resistant Mycobacterium tuberculosis",
abstract = "The potent antimycobacterial activity of (±)-platencin is reported. Complete inhibition of Mycobacterium smegmatis growth was observed at MICs of 0.5 μg mL-1 and 0.3 μg mL-1 under aerobic and hypoxic conditions, respectively. Notably, the compound exhibited potent bacteriostatic activities towards Mycobacterium tuberculosis H37Rv (MIC = 2 μg mL-1), multi-drug-resistant M. tuberculosis (MIC = 1 μg mL-1), and extensively drug-resistant M. tuberculosis (MIC = 1 μg mL-1). An overexpression study of the transformants of M. smegmatis revealed that platencin selectively targeted Mt-KasB and modestly inhibited Mt-KasA and Mt-FabH.",
author = "Moustafa, {Gamal A I} and Shoji Nojima and Yoshi Yamano and Akio Aono and Masayoshi Arai and Satoshi Mitarai and Tetsuaki Tanaka and Takehiko Yoshimitsu",
year = "2013",
doi = "10.1039/c3md00016h",
language = "English",
volume = "4",
pages = "720--723",
journal = "MedChemComm",
issn = "2040-2503",
publisher = "Royal Society of Chemistry",
number = "4",

}

TY - JOUR

T1 - Potent growth inhibitory activity of (±)-platencin towards multi-drug-resistant and extensively drug-resistant Mycobacterium tuberculosis

AU - Moustafa, Gamal A I

AU - Nojima, Shoji

AU - Yamano, Yoshi

AU - Aono, Akio

AU - Arai, Masayoshi

AU - Mitarai, Satoshi

AU - Tanaka, Tetsuaki

AU - Yoshimitsu, Takehiko

PY - 2013

Y1 - 2013

N2 - The potent antimycobacterial activity of (±)-platencin is reported. Complete inhibition of Mycobacterium smegmatis growth was observed at MICs of 0.5 μg mL-1 and 0.3 μg mL-1 under aerobic and hypoxic conditions, respectively. Notably, the compound exhibited potent bacteriostatic activities towards Mycobacterium tuberculosis H37Rv (MIC = 2 μg mL-1), multi-drug-resistant M. tuberculosis (MIC = 1 μg mL-1), and extensively drug-resistant M. tuberculosis (MIC = 1 μg mL-1). An overexpression study of the transformants of M. smegmatis revealed that platencin selectively targeted Mt-KasB and modestly inhibited Mt-KasA and Mt-FabH.

AB - The potent antimycobacterial activity of (±)-platencin is reported. Complete inhibition of Mycobacterium smegmatis growth was observed at MICs of 0.5 μg mL-1 and 0.3 μg mL-1 under aerobic and hypoxic conditions, respectively. Notably, the compound exhibited potent bacteriostatic activities towards Mycobacterium tuberculosis H37Rv (MIC = 2 μg mL-1), multi-drug-resistant M. tuberculosis (MIC = 1 μg mL-1), and extensively drug-resistant M. tuberculosis (MIC = 1 μg mL-1). An overexpression study of the transformants of M. smegmatis revealed that platencin selectively targeted Mt-KasB and modestly inhibited Mt-KasA and Mt-FabH.

UR - http://www.scopus.com/inward/record.url?scp=84876701501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876701501&partnerID=8YFLogxK

U2 - 10.1039/c3md00016h

DO - 10.1039/c3md00016h

M3 - Article

VL - 4

SP - 720

EP - 723

JO - MedChemComm

JF - MedChemComm

SN - 2040-2503

IS - 4

ER -